Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.35 - $2.12 $66,263 - $104,058
49,084 Added 112.06%
92,885 $132,000
Q4 2023

Feb 14, 2024

BUY
$1.2 - $2.13 $20,370 - $36,156
16,975 Added 63.28%
43,801 $80,000
Q3 2023

Nov 14, 2023

BUY
$1.04 - $1.74 $14,193 - $23,747
13,648 Added 103.57%
26,826 $44,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.88 $14,759 - $24,774
13,178 New
13,178 $16,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.